Research ArticleArticle
Response to Tocilizumab in Rheumatoid Arthritis Is Not Influenced by the Body Mass Index of the Patient
Yves-Marie Pers, Marie Godfrin-Valnet, Joseph Lambert, Clémentine Fortuet, Elodie Constant, Thibault Mura, Béatrice Pallot-Prades, Christian Jorgensen, Jean-Francis Maillefert, Hubert Marotte, Daniel Wendling and Philippe Gaudin
The Journal of Rheumatology February 2015, jrheum.140673; DOI: https://doi.org/10.3899/jrheum.140673
Yves-Marie Pers
From the Clinical Immunology and Osteoarticular Diseases Therapeutic Unit, Lapeyronie University Hospital; INSERM CIC 1001, Arnaud de Villeneuve University Hospital, Montpellier; Rheumatology, Besançon University Teaching Hospital, Besançon; Rheumatology Unit, Grenoble University Hospital, Grenoble; Rheumatology, Dijon University Hospital, Dijon; Rheumatology Unit, Saint-Étienne University Hospital, Saint-Étienne, France. Y-M. Pers, MD; C. Jorgensen, MD, PhD, Clinical Immunology and Osteoarticular Diseases Therapeutic Unit, Lapeyronie University Hospital; M. Godfrin-Valnet, MD; D. Wendling, MD, PhD, Rheumatology, Besançon University Teaching Hospital; J. Lambert, MD; P. Gaudin, MD, PhD, Rheumatology Unit, Grenoble University Hospital; C. Fortunet, MD; J-F. Maillefert, MD, PhD, Rheumatology, Dijon University Hospital; E. Constant, MD; B. Pallot-Prades, MD; H. Marotte, MD, PhD, Rheumatology Unit, Saint-Etienne University Hospital; T. Mura, MD, PhD, INSERM CIC 1001, Arnaud de Villeneuve University Hospital. Address correspondence to Dr. Y-M. Pers, Clinical Immunology and Osteoarticular Diseases Therapeutic Unit, CHRU Lapeyronie, 371 Avenue du Doyen Gaston Giraud, 34295 Montpellier, France. E-mail: ympers2000@yahoo.fr. Accepted for publication December 10, 2014.
Marie Godfrin-Valnet
From the Clinical Immunology and Osteoarticular Diseases Therapeutic Unit, Lapeyronie University Hospital; INSERM CIC 1001, Arnaud de Villeneuve University Hospital, Montpellier; Rheumatology, Besançon University Teaching Hospital, Besançon; Rheumatology Unit, Grenoble University Hospital, Grenoble; Rheumatology, Dijon University Hospital, Dijon; Rheumatology Unit, Saint-Étienne University Hospital, Saint-Étienne, France. Y-M. Pers, MD; C. Jorgensen, MD, PhD, Clinical Immunology and Osteoarticular Diseases Therapeutic Unit, Lapeyronie University Hospital; M. Godfrin-Valnet, MD; D. Wendling, MD, PhD, Rheumatology, Besançon University Teaching Hospital; J. Lambert, MD; P. Gaudin, MD, PhD, Rheumatology Unit, Grenoble University Hospital; C. Fortunet, MD; J-F. Maillefert, MD, PhD, Rheumatology, Dijon University Hospital; E. Constant, MD; B. Pallot-Prades, MD; H. Marotte, MD, PhD, Rheumatology Unit, Saint-Etienne University Hospital; T. Mura, MD, PhD, INSERM CIC 1001, Arnaud de Villeneuve University Hospital. Address correspondence to Dr. Y-M. Pers, Clinical Immunology and Osteoarticular Diseases Therapeutic Unit, CHRU Lapeyronie, 371 Avenue du Doyen Gaston Giraud, 34295 Montpellier, France. E-mail: ympers2000@yahoo.fr. Accepted for publication December 10, 2014.
Joseph Lambert
From the Clinical Immunology and Osteoarticular Diseases Therapeutic Unit, Lapeyronie University Hospital; INSERM CIC 1001, Arnaud de Villeneuve University Hospital, Montpellier; Rheumatology, Besançon University Teaching Hospital, Besançon; Rheumatology Unit, Grenoble University Hospital, Grenoble; Rheumatology, Dijon University Hospital, Dijon; Rheumatology Unit, Saint-Étienne University Hospital, Saint-Étienne, France. Y-M. Pers, MD; C. Jorgensen, MD, PhD, Clinical Immunology and Osteoarticular Diseases Therapeutic Unit, Lapeyronie University Hospital; M. Godfrin-Valnet, MD; D. Wendling, MD, PhD, Rheumatology, Besançon University Teaching Hospital; J. Lambert, MD; P. Gaudin, MD, PhD, Rheumatology Unit, Grenoble University Hospital; C. Fortunet, MD; J-F. Maillefert, MD, PhD, Rheumatology, Dijon University Hospital; E. Constant, MD; B. Pallot-Prades, MD; H. Marotte, MD, PhD, Rheumatology Unit, Saint-Etienne University Hospital; T. Mura, MD, PhD, INSERM CIC 1001, Arnaud de Villeneuve University Hospital. Address correspondence to Dr. Y-M. Pers, Clinical Immunology and Osteoarticular Diseases Therapeutic Unit, CHRU Lapeyronie, 371 Avenue du Doyen Gaston Giraud, 34295 Montpellier, France. E-mail: ympers2000@yahoo.fr. Accepted for publication December 10, 2014.
Clémentine Fortuet
From the Clinical Immunology and Osteoarticular Diseases Therapeutic Unit, Lapeyronie University Hospital; INSERM CIC 1001, Arnaud de Villeneuve University Hospital, Montpellier; Rheumatology, Besançon University Teaching Hospital, Besançon; Rheumatology Unit, Grenoble University Hospital, Grenoble; Rheumatology, Dijon University Hospital, Dijon; Rheumatology Unit, Saint-Étienne University Hospital, Saint-Étienne, France. Y-M. Pers, MD; C. Jorgensen, MD, PhD, Clinical Immunology and Osteoarticular Diseases Therapeutic Unit, Lapeyronie University Hospital; M. Godfrin-Valnet, MD; D. Wendling, MD, PhD, Rheumatology, Besançon University Teaching Hospital; J. Lambert, MD; P. Gaudin, MD, PhD, Rheumatology Unit, Grenoble University Hospital; C. Fortunet, MD; J-F. Maillefert, MD, PhD, Rheumatology, Dijon University Hospital; E. Constant, MD; B. Pallot-Prades, MD; H. Marotte, MD, PhD, Rheumatology Unit, Saint-Etienne University Hospital; T. Mura, MD, PhD, INSERM CIC 1001, Arnaud de Villeneuve University Hospital. Address correspondence to Dr. Y-M. Pers, Clinical Immunology and Osteoarticular Diseases Therapeutic Unit, CHRU Lapeyronie, 371 Avenue du Doyen Gaston Giraud, 34295 Montpellier, France. E-mail: ympers2000@yahoo.fr. Accepted for publication December 10, 2014.
Elodie Constant
From the Clinical Immunology and Osteoarticular Diseases Therapeutic Unit, Lapeyronie University Hospital; INSERM CIC 1001, Arnaud de Villeneuve University Hospital, Montpellier; Rheumatology, Besançon University Teaching Hospital, Besançon; Rheumatology Unit, Grenoble University Hospital, Grenoble; Rheumatology, Dijon University Hospital, Dijon; Rheumatology Unit, Saint-Étienne University Hospital, Saint-Étienne, France. Y-M. Pers, MD; C. Jorgensen, MD, PhD, Clinical Immunology and Osteoarticular Diseases Therapeutic Unit, Lapeyronie University Hospital; M. Godfrin-Valnet, MD; D. Wendling, MD, PhD, Rheumatology, Besançon University Teaching Hospital; J. Lambert, MD; P. Gaudin, MD, PhD, Rheumatology Unit, Grenoble University Hospital; C. Fortunet, MD; J-F. Maillefert, MD, PhD, Rheumatology, Dijon University Hospital; E. Constant, MD; B. Pallot-Prades, MD; H. Marotte, MD, PhD, Rheumatology Unit, Saint-Etienne University Hospital; T. Mura, MD, PhD, INSERM CIC 1001, Arnaud de Villeneuve University Hospital. Address correspondence to Dr. Y-M. Pers, Clinical Immunology and Osteoarticular Diseases Therapeutic Unit, CHRU Lapeyronie, 371 Avenue du Doyen Gaston Giraud, 34295 Montpellier, France. E-mail: ympers2000@yahoo.fr. Accepted for publication December 10, 2014.
Thibault Mura
From the Clinical Immunology and Osteoarticular Diseases Therapeutic Unit, Lapeyronie University Hospital; INSERM CIC 1001, Arnaud de Villeneuve University Hospital, Montpellier; Rheumatology, Besançon University Teaching Hospital, Besançon; Rheumatology Unit, Grenoble University Hospital, Grenoble; Rheumatology, Dijon University Hospital, Dijon; Rheumatology Unit, Saint-Étienne University Hospital, Saint-Étienne, France. Y-M. Pers, MD; C. Jorgensen, MD, PhD, Clinical Immunology and Osteoarticular Diseases Therapeutic Unit, Lapeyronie University Hospital; M. Godfrin-Valnet, MD; D. Wendling, MD, PhD, Rheumatology, Besançon University Teaching Hospital; J. Lambert, MD; P. Gaudin, MD, PhD, Rheumatology Unit, Grenoble University Hospital; C. Fortunet, MD; J-F. Maillefert, MD, PhD, Rheumatology, Dijon University Hospital; E. Constant, MD; B. Pallot-Prades, MD; H. Marotte, MD, PhD, Rheumatology Unit, Saint-Etienne University Hospital; T. Mura, MD, PhD, INSERM CIC 1001, Arnaud de Villeneuve University Hospital. Address correspondence to Dr. Y-M. Pers, Clinical Immunology and Osteoarticular Diseases Therapeutic Unit, CHRU Lapeyronie, 371 Avenue du Doyen Gaston Giraud, 34295 Montpellier, France. E-mail: ympers2000@yahoo.fr. Accepted for publication December 10, 2014.
Béatrice Pallot-Prades
From the Clinical Immunology and Osteoarticular Diseases Therapeutic Unit, Lapeyronie University Hospital; INSERM CIC 1001, Arnaud de Villeneuve University Hospital, Montpellier; Rheumatology, Besançon University Teaching Hospital, Besançon; Rheumatology Unit, Grenoble University Hospital, Grenoble; Rheumatology, Dijon University Hospital, Dijon; Rheumatology Unit, Saint-Étienne University Hospital, Saint-Étienne, France. Y-M. Pers, MD; C. Jorgensen, MD, PhD, Clinical Immunology and Osteoarticular Diseases Therapeutic Unit, Lapeyronie University Hospital; M. Godfrin-Valnet, MD; D. Wendling, MD, PhD, Rheumatology, Besançon University Teaching Hospital; J. Lambert, MD; P. Gaudin, MD, PhD, Rheumatology Unit, Grenoble University Hospital; C. Fortunet, MD; J-F. Maillefert, MD, PhD, Rheumatology, Dijon University Hospital; E. Constant, MD; B. Pallot-Prades, MD; H. Marotte, MD, PhD, Rheumatology Unit, Saint-Etienne University Hospital; T. Mura, MD, PhD, INSERM CIC 1001, Arnaud de Villeneuve University Hospital. Address correspondence to Dr. Y-M. Pers, Clinical Immunology and Osteoarticular Diseases Therapeutic Unit, CHRU Lapeyronie, 371 Avenue du Doyen Gaston Giraud, 34295 Montpellier, France. E-mail: ympers2000@yahoo.fr. Accepted for publication December 10, 2014.
Christian Jorgensen
From the Clinical Immunology and Osteoarticular Diseases Therapeutic Unit, Lapeyronie University Hospital; INSERM CIC 1001, Arnaud de Villeneuve University Hospital, Montpellier; Rheumatology, Besançon University Teaching Hospital, Besançon; Rheumatology Unit, Grenoble University Hospital, Grenoble; Rheumatology, Dijon University Hospital, Dijon; Rheumatology Unit, Saint-Étienne University Hospital, Saint-Étienne, France. Y-M. Pers, MD; C. Jorgensen, MD, PhD, Clinical Immunology and Osteoarticular Diseases Therapeutic Unit, Lapeyronie University Hospital; M. Godfrin-Valnet, MD; D. Wendling, MD, PhD, Rheumatology, Besançon University Teaching Hospital; J. Lambert, MD; P. Gaudin, MD, PhD, Rheumatology Unit, Grenoble University Hospital; C. Fortunet, MD; J-F. Maillefert, MD, PhD, Rheumatology, Dijon University Hospital; E. Constant, MD; B. Pallot-Prades, MD; H. Marotte, MD, PhD, Rheumatology Unit, Saint-Etienne University Hospital; T. Mura, MD, PhD, INSERM CIC 1001, Arnaud de Villeneuve University Hospital. Address correspondence to Dr. Y-M. Pers, Clinical Immunology and Osteoarticular Diseases Therapeutic Unit, CHRU Lapeyronie, 371 Avenue du Doyen Gaston Giraud, 34295 Montpellier, France. E-mail: ympers2000@yahoo.fr. Accepted for publication December 10, 2014.
Jean-Francis Maillefert
From the Clinical Immunology and Osteoarticular Diseases Therapeutic Unit, Lapeyronie University Hospital; INSERM CIC 1001, Arnaud de Villeneuve University Hospital, Montpellier; Rheumatology, Besançon University Teaching Hospital, Besançon; Rheumatology Unit, Grenoble University Hospital, Grenoble; Rheumatology, Dijon University Hospital, Dijon; Rheumatology Unit, Saint-Étienne University Hospital, Saint-Étienne, France. Y-M. Pers, MD; C. Jorgensen, MD, PhD, Clinical Immunology and Osteoarticular Diseases Therapeutic Unit, Lapeyronie University Hospital; M. Godfrin-Valnet, MD; D. Wendling, MD, PhD, Rheumatology, Besançon University Teaching Hospital; J. Lambert, MD; P. Gaudin, MD, PhD, Rheumatology Unit, Grenoble University Hospital; C. Fortunet, MD; J-F. Maillefert, MD, PhD, Rheumatology, Dijon University Hospital; E. Constant, MD; B. Pallot-Prades, MD; H. Marotte, MD, PhD, Rheumatology Unit, Saint-Etienne University Hospital; T. Mura, MD, PhD, INSERM CIC 1001, Arnaud de Villeneuve University Hospital. Address correspondence to Dr. Y-M. Pers, Clinical Immunology and Osteoarticular Diseases Therapeutic Unit, CHRU Lapeyronie, 371 Avenue du Doyen Gaston Giraud, 34295 Montpellier, France. E-mail: ympers2000@yahoo.fr. Accepted for publication December 10, 2014.
Hubert Marotte
From the Clinical Immunology and Osteoarticular Diseases Therapeutic Unit, Lapeyronie University Hospital; INSERM CIC 1001, Arnaud de Villeneuve University Hospital, Montpellier; Rheumatology, Besançon University Teaching Hospital, Besançon; Rheumatology Unit, Grenoble University Hospital, Grenoble; Rheumatology, Dijon University Hospital, Dijon; Rheumatology Unit, Saint-Étienne University Hospital, Saint-Étienne, France. Y-M. Pers, MD; C. Jorgensen, MD, PhD, Clinical Immunology and Osteoarticular Diseases Therapeutic Unit, Lapeyronie University Hospital; M. Godfrin-Valnet, MD; D. Wendling, MD, PhD, Rheumatology, Besançon University Teaching Hospital; J. Lambert, MD; P. Gaudin, MD, PhD, Rheumatology Unit, Grenoble University Hospital; C. Fortunet, MD; J-F. Maillefert, MD, PhD, Rheumatology, Dijon University Hospital; E. Constant, MD; B. Pallot-Prades, MD; H. Marotte, MD, PhD, Rheumatology Unit, Saint-Etienne University Hospital; T. Mura, MD, PhD, INSERM CIC 1001, Arnaud de Villeneuve University Hospital. Address correspondence to Dr. Y-M. Pers, Clinical Immunology and Osteoarticular Diseases Therapeutic Unit, CHRU Lapeyronie, 371 Avenue du Doyen Gaston Giraud, 34295 Montpellier, France. E-mail: ympers2000@yahoo.fr. Accepted for publication December 10, 2014.
Daniel Wendling
From the Clinical Immunology and Osteoarticular Diseases Therapeutic Unit, Lapeyronie University Hospital; INSERM CIC 1001, Arnaud de Villeneuve University Hospital, Montpellier; Rheumatology, Besançon University Teaching Hospital, Besançon; Rheumatology Unit, Grenoble University Hospital, Grenoble; Rheumatology, Dijon University Hospital, Dijon; Rheumatology Unit, Saint-Étienne University Hospital, Saint-Étienne, France. Y-M. Pers, MD; C. Jorgensen, MD, PhD, Clinical Immunology and Osteoarticular Diseases Therapeutic Unit, Lapeyronie University Hospital; M. Godfrin-Valnet, MD; D. Wendling, MD, PhD, Rheumatology, Besançon University Teaching Hospital; J. Lambert, MD; P. Gaudin, MD, PhD, Rheumatology Unit, Grenoble University Hospital; C. Fortunet, MD; J-F. Maillefert, MD, PhD, Rheumatology, Dijon University Hospital; E. Constant, MD; B. Pallot-Prades, MD; H. Marotte, MD, PhD, Rheumatology Unit, Saint-Etienne University Hospital; T. Mura, MD, PhD, INSERM CIC 1001, Arnaud de Villeneuve University Hospital. Address correspondence to Dr. Y-M. Pers, Clinical Immunology and Osteoarticular Diseases Therapeutic Unit, CHRU Lapeyronie, 371 Avenue du Doyen Gaston Giraud, 34295 Montpellier, France. E-mail: ympers2000@yahoo.fr. Accepted for publication December 10, 2014.
Philippe Gaudin
From the Clinical Immunology and Osteoarticular Diseases Therapeutic Unit, Lapeyronie University Hospital; INSERM CIC 1001, Arnaud de Villeneuve University Hospital, Montpellier; Rheumatology, Besançon University Teaching Hospital, Besançon; Rheumatology Unit, Grenoble University Hospital, Grenoble; Rheumatology, Dijon University Hospital, Dijon; Rheumatology Unit, Saint-Étienne University Hospital, Saint-Étienne, France. Y-M. Pers, MD; C. Jorgensen, MD, PhD, Clinical Immunology and Osteoarticular Diseases Therapeutic Unit, Lapeyronie University Hospital; M. Godfrin-Valnet, MD; D. Wendling, MD, PhD, Rheumatology, Besançon University Teaching Hospital; J. Lambert, MD; P. Gaudin, MD, PhD, Rheumatology Unit, Grenoble University Hospital; C. Fortunet, MD; J-F. Maillefert, MD, PhD, Rheumatology, Dijon University Hospital; E. Constant, MD; B. Pallot-Prades, MD; H. Marotte, MD, PhD, Rheumatology Unit, Saint-Etienne University Hospital; T. Mura, MD, PhD, INSERM CIC 1001, Arnaud de Villeneuve University Hospital. Address correspondence to Dr. Y-M. Pers, Clinical Immunology and Osteoarticular Diseases Therapeutic Unit, CHRU Lapeyronie, 371 Avenue du Doyen Gaston Giraud, 34295 Montpellier, France. E-mail: ympers2000@yahoo.fr. Accepted for publication December 10, 2014.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Response to Tocilizumab in Rheumatoid Arthritis Is Not Influenced by the Body Mass Index of the Patient
Yves-Marie Pers, Marie Godfrin-Valnet, Joseph Lambert, Clémentine Fortuet, Elodie Constant, Thibault Mura, Béatrice Pallot-Prades, Christian Jorgensen, Jean-Francis Maillefert, Hubert Marotte, Daniel Wendling, Philippe Gaudin
The Journal of Rheumatology Feb 2015, jrheum.140673; DOI: 10.3899/jrheum.140673
Response to Tocilizumab in Rheumatoid Arthritis Is Not Influenced by the Body Mass Index of the Patient
Yves-Marie Pers, Marie Godfrin-Valnet, Joseph Lambert, Clémentine Fortuet, Elodie Constant, Thibault Mura, Béatrice Pallot-Prades, Christian Jorgensen, Jean-Francis Maillefert, Hubert Marotte, Daniel Wendling, Philippe Gaudin
The Journal of Rheumatology Feb 2015, jrheum.140673; DOI: 10.3899/jrheum.140673